http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03026397-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b5c3d199d39c9e72eb1d2a319ce50202
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b191dcdff1b949e72501c1ace7178e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7fe256f2e07b1769466465082fbd31ac
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-723
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-02
filingDate 2002-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_279fee74b7ba8623e887c80677cf0f8b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ebe91ab96a5a2b8d6b955265f163d080
publicationDate 2003-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-03026397-A3
titleOfInvention Thyrotropin releasing hormone receptor disruptions, compositions and methods relating thereto
abstract The present invention relates to compositions and methods relating to the characterization and function of the TRH receptor. Specifically, the present invention provides transgenic animals comprising disruptions in a TRH receptor gene and methods of treating diseases conditions, such as diabetes related disorders, anxiety, pain and epilepsy. The present invention further relates to agents that modulate the TRH receptor and methods of screening for agents that modulate TRH receptor for the treatment of diseases and conditions such as diabetes related disorders, anxiety, pain and epilepsy.
priorityDate 2001-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002088012-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5919997-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID638678
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420062

Total number of triples: 22.